ASCO 2019: Entrectinib gets edge over crizotinib against ROS1 lung cancer
Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…
Browsing: “virtual” clinical trial
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Scientists identify potential drug candidates for deadly paediatric leukaemia
- Protein found to control drivers of normal growth and cancer
- Cellular “hotspots” in the brain may signify the earliest signs of cancer
- Researchers establish intracellular interaction network in breast cancer
- How transcription factors work together in cancer formation
- Diabetes drug shows potential in fighting cancer
- Set of genetic markers in lung cancer identified
- Brachytherapy may continue following uterine perforation in cervical cancer patients
